• NASH market forecast to be worth $18.3bn by 2026 pharmaceutical-technology
    January 03, 2019
    Due to increasing rates of obesity and diabetes, non-alcoholic steatohepatitis (NASH), a chronic inflammatory liver disease, is becoming increasingly prevalent.
  • Drug discovery outsourcing market forecast 2017-2025 europeanpharmaceuticalreview
    October 24, 2018
    A market report has given a complete backdrop analysis of the pharmaceutical drug discovery outsourcing market, including market growth and shares…
PharmaSources Customer Service